Latest Europe News

Sweden's Parliament has amended legislation to remove uranium mining from nuclear facility regulations, simplifying permits and strengthening Aura Energy's prospects for its Häggån uranium deposit.

Goodman Group (ASX:GMG) has announced an estimated unfranked distribution of AUD 0.15 per stapled security for the six months ending 30 June 2026, maintaining its steady income stream for investors.

Memphasys has locked in a 12-month exclusive supply agreement with Monash IVF for its Felix™ sperm selection system, marking its biggest commercial contract to date and setting a foundation for recurring revenue.

European Resources has significantly expanded the exploration potential at its Korsnäs rare earth project in Finland, increasing the Exploration Target by up to 190% to between 18 and 32 million tonnes at 0.8% to 1.0% TREO. This growth follows new passive seismic survey results and geological modelling extending mineralisation down to -400 m RL.

Krakatoa Resources is gearing up to resume drilling at its Zopkhito antimony-gold project in Georgia, buoyed by strong 2025 results and a two-year extension to its exploration license.

Simble Solutions edges closer to $1 million in annual recurring revenue as major customer rollouts advance and its NanoSensor program moves forward along a structured development pathway.

Electro Optic Systems (ASX:EOS) reports sustained demand driven by global conflicts, launches MARSS business in Europe, and updates 2026 revenue outlook with base business guidance of $240m to $270m.

GCM Corporation expands its VHD heat sink portfolio to 44 products and moves into liquid cooling OEM markets for AI servers, securing global distribution via DigiKey.

TruScreen has secured clinical validation from the world’s largest cervical screening study in China, setting the stage for rapid market expansion across Asia, Africa, and Europe.

Meteoric Resources has reported exceptional pilot plant performance at its Caldeira Rare Earth Project in Brazil, achieving magnet rare earth oxide recoveries of 80% in May and exceeding pre-feasibility study targets.

Lendlease appoints seasoned real asset executive Nick O’Neil as CEO, marking a leadership shift aligned with its strategic reset and portfolio simplification.

ImpediMed has successfully closed an oversubscribed Share Purchase Plan, raising $2.1 million following a $13.2 million institutional placement. The strong shareholder response underscores confidence ahead of a key shareholder vote.